Danaher Corporation announced a major definitive agreement to acquire Masimo Corporation for approximately $9.9 billion to significantly expand its diagnostics and advanced patient monitoring portfolios. This strategic acquisition allows Danaher to integrate Masimo's industry-leading medical technologies, such as advanced pulse oximetry, non-invasive monitoring hardware, and hospital automation solutions, into its broader life sciences and diagnostics ecosystem, reinforcing its market presence and driving long-term clinical innovation revenue growth.